Mechanisms Underlying Impaired Diabetic Wound Healing
ConditionNon-healing Wound
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21-80
SponsorUniversity of Pittsburgh
About this trial
The overall aim of this research is to utilize wound derived inflammatory cells from diabetic versus non diabetic human chronic wounds to understand mechanisms that are responsible for disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood derived cells) versus wound derived cells will also be studied.
Eligibility criteria
Qualifiers
Ages 21-80
Chronic Wound (present >4 weeks)
Diabetic & Non-diabetic
Adult surgical wounds
Disqualifiers
Inability to consent
Pregnant women
Therapeutically immunocompromised
Individuals defined in 45 CFR 46 Subparts B,C, and D, nor from any other population considered vulnerable 2.9
Trial design
Treatments tested in this trial
- Blood draw
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov